My Abdelilah Melhouf
Research Subjects
My Abdelilah Melhouf has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Sofia Jayi
Department of Gynecology, Hassan II teaching hospital, Fez, Morocco
5 shared publications - Hinde El Fatemi
Department of Pathology, Hassan II University Hospital, Fez, Morocco
4 shared publications - Afaf Amarti
Department of Pathology, Hassan II University Hospital, Fez, Morocco
3 shared publications - Abdelaziz Bannani
Department of Gynecology, Hassan II teaching hospital, Fez, Morocco
2 shared publications Afaf Laamarti
Department of Anatomopathology, University Hospital of Fez, Fez, Morocco
2 shared publications- Fatima Zohra Fdili
Department of Gynecology and Obstetrics, University Hospital of Fez, Fez, Morocco
2 shared publications
Latest Publications
- Open Access
- 26 December 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 465
Granular cell tumor of the breast: a case report
A granular cell tumor involving the breast parenchyma was first described by Abrikossoff in 1931. Localization of this lesion to the breast is very rare, accounting for between 5% and 15% of all granular cell tumor cases. We present this case because of the rarity of this tumor. It is frequently confused with breast carcinoma on clinical and radiological examination, and its diagnosis can therefore be challenging for clinicians, radiologists and pathologists.
- 26 December 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 465
Open AccessGranular cell tumor of the breast: a case report
A granular cell tumor involving the breast parenchyma was first described by Abrikossoff in 1931. Localization of this lesion to the breast is very rare, accounting for between 5% and 15% of all granular cell tumor cases. We present this case because of the rarity of this tumor. It is frequently confused with breast carcinoma on clinical and radiological examination, and its diagnosis can therefore be challenging for clinicians, radiologists and pathologists.
- Open Access
- 1 July 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 241
Embryonal rhabdomyosarcoma of the cervix presenting as a cervical polyp in a 16-year-old adolescent: a case report
Embryonal rhabdomyosarcoma of the female genital tract is rare in the cervix. It has been mainly discussed in the context of individual case studies. It tends to occur in children and young women. Treatment ranges from radical surgery to conservative surgery, followed by chemotherapy.
- 1 July 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 241
Open AccessEmbryonal rhabdomyosarcoma of the cervix presenting as a cervical polyp in a 16-year-old adolescent: a case report
Embryonal rhabdomyosarcoma of the female genital tract is rare in the cervix. It has been mainly discussed in the context of individual case studies. It tends to occur in children and young women. Treatment ranges from radical surgery to conservative surgery, followed by chemotherapy.
- Open Access
- 18 June 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 203
Vulvar lipoma: a case report
Vulvar lipoma is a rare tumor localization and only a few cases have been reported. The clinical characteristics of vulvar lipoma are well known. However, it is important to distinguish lipomas from liposarcomas. We report a case of vulvar lipoma and discuss its clinical features, including diagnostic aspects, with emphasis on histopathological evaluation of all excised lesions. We also report and discuss patient management and treatment outcomes.
- 18 June 2014
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 203
Open AccessVulvar lipoma: a case report
Vulvar lipoma is a rare tumor localization and only a few cases have been reported. The clinical characteristics of vulvar lipoma are well known. However, it is important to distinguish lipomas from liposarcomas. We report a case of vulvar lipoma and discuss its clinical features, including diagnostic aspects, with emphasis on histopathological evaluation of all excised lesions. We also report and discuss patient management and treatment outcomes.
- RetractionOpen Access
- 14 August 2013
- Published by Springer Nature in Diagnostic Pathology
- Vol. 8 (1) , 127
Retraction Note: Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco
- 14 August 2013
- Published by Springer Nature in Diagnostic Pathology
- Vol. 8 (1) , 127
RetractionOpen AccessRetraction Note: Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco
- RetractedOpen Access
- 7 December 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 170
Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco
Background: Breast cancer may be classified into luminal A, luminal B, HER2+/ER-, basal-like and normal-like subtypes based on gene expression profiling or immunohistochemical (IHC) characteristics. The aim of our study is to show the molecular profile characteristic of breast cancer in the North African population of Morocco. This work showed preliminary results and correlations with clinicopathological and histological parameters. Three hundred and ninety primary breast carcinomas tumor tissues were immunostained for ER, PR, HER2, CK5/6, CK8/18 and Ki67 using paraffin tissue. Methods: We reviewed 390 cases of breast cancer diagnosed on January 2008 to December 2011 at the Department of pathology, Hassan II teaching hospital, Fez, Morocco. Age, size tumor, metastatic profile, node involvement profile, histological type and immunohistochemical profile were studied. Results: The average age was 46 years; our patients were diagnosed late with a high average tumor size. Luminal B subtype was more prevalent (41.8%), followed by luminal A (30.5%), basal-like (13, 6%), Her2-overexpressing (9, 2%), and unclassified subtype (4.9%). Conclusion: This study showed that molecular classification and biological profile may be different according to geographical distribution, to encourage further studies to know the genomic profile of tumors and the environment. Virtual slide: http://www.diagnosticpathology.diagnomx.eu/vs/1675272504826544
- 7 December 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 170
RetractedOpen AccessLuminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco
Background: Breast cancer may be classified into luminal A, luminal B, HER2+/ER-, basal-like and normal-like subtypes based on gene expression profiling or immunohistochemical (IHC) characteristics. The aim of our study is to show the molecular profile characteristic of breast cancer in the North African population of Morocco. This work showed preliminary results and correlations with clinicopathological and histological parameters. Three hundred and ninety primary breast carcinomas tumor tissues were immunostained for ER, PR, HER2, CK5/6, CK8/18 and Ki67 using paraffin tissue. Methods: We reviewed 390 cases of breast cancer diagnosed on January 2008 to December 2011 at the Department of pathology, Hassan II teaching hospital, Fez, Morocco. Age, size tumor, metastatic profile, node involvement profile, histological type and immunohistochemical profile were studied. Results: The average age was 46 years; our patients were diagnosed late with a high average tumor size. Luminal B subtype was more prevalent (41.8%), followed by luminal A (30.5%), basal-like (13, 6%), Her2-overexpressing (9, 2%), and unclassified subtype (4.9%). Conclusion: This study showed that molecular classification and biological profile may be different according to geographical distribution, to encourage further studies to know the genomic profile of tumors and the environment. Virtual slide: http://www.diagnosticpathology.diagnomx.eu/vs/1675272504826544